The global personalized therapy biosimulation market size reached USD 1,061.7 Million in 2020 and is expected to register a revenue CAGR of 14.6%, during the forecast period, according to latest analysis by Emergen Research. Rising incidence of drug relapse and drug resistance cases and increasing application of quantitative system pharmacology in drug development processes are some key factors driving global personalized therapy biosimulation market revenue growth.
Drug development is a lengthy, complex, multifaceted, and costly process, with high failure rates and fewer number of drugs receiving U.S. Food & Drug Administration (FDA) approval. The low success rate, increasing R&D expenditure, rising incidence of drug resistance in cancer, epilepsy, and tuberculosis among others are some factors driving rising need for incorporating biosimulation technique for the development of new generation of drugs. Majority of patients show resistance to novel targeted drugs or classical chemotherapeutic agents and do not respond to standard cancer treatment options such as chemotherapy and radiation therapy, thereby leading to higher cancer recurrence rate.
In recent years, majority of biopharmaceutical companies have been employing modelling and simulation techniques in drug discovery and development process, ranging from target identification and validation, through analysis of preclinical data to analysis of phase-I, II, and III clinical trial data for optimizing doses for safety and efficacy. Hence, majority of pharmaceutical and biotechnology companies are incorporating biosimulation in clinical studies to determine a patient’s Therapy Response Index (TRI) to understand whether a patient will respond to standard care treatment, identify optimal therapies and thereby improve clinical efficacy, avoid ineffective treatment, and improve overall survival rate of patients. This is expected to drive growth of the market to a significant extent going ahead.
Personalized Therapy Biosimulation Market Forecast to 2028”. The report sheds light on the current as well as upcoming market trends. The report offers precise information about pricing, capacity, value, gross revenue, and profit of the market. The primary aim of the report is to offer in depth details about market size, revenue growth and overall market dynamics to readers, stakeholders, companies to strengthen their share in the global Personalized Therapy Biosimulation market. It also provides in depth information about key factors, restraints, limitations, challenges along with various market segmentations such as product type, application and regional bifurcation.
This study aims to define market sizes and forecast the values for different segments and countries in the coming eight years. The study aims to include qualitative and quantitative perspectives about the industry within the regions and countries covered in the report. The report also outlines the significant factors, such as driving factors and challenges, that will determine the market’s future growth.
Get Free Sample PDF Copy Of This Report At: https://www.emergenresearch.com/request-sample/785
Some Key Highlights From the Report
Software segment is expected to account for largest revenue share over the forecast period due to increasing adoption of biosimulation software by pharmaceutical and biotechnology companies, Contract Research Organizations, regulatory agencies, and academic and research institutes to accelerate drug development process and rapid technological advancements and up-gradation in the software.
Oncology segment revenue is expected to expand at a rapid CAGR over the forecast period owing to rising prevalence of cancer, increasing adoption of personalized medicine approach for cancer treatment and increasing use of biosimulation platform to predict individual response to cancer therapeutics and minimize drug resistance among cancer patients.
Drug discovery segment revenue is expected to register a significantly robust CAGR over the forecast period owing to increasing use of biosimulation technique in drug discovery process ranging from target validation, lead identification, lead optimization, to product characterization.
The Regional Global Market Research Personalized Therapy Biosimulation helps business players to gain a comprehensive understanding of the development of various geographic markets in recent years and in the future. Furthermore, the report provides a comprehensive overview of vital dynamics of the global Personalized Therapy Biosimulation industry, including market and market influencers, driving forces, threats, restraints, trends and prospects.
Key players are strategizing various plans such as M&A acquisition, partnerships, joint ventures, license agreement and collaborations. Cellworks Group Inc., Certara USA Inc., Simulation Plus Inc., Schrodinger Inc., In Silico Biosciences Inc., Genedata AG, Physiomics plc, Insilico Biotechology AG, Chemical Computing Group ULC (CCG), and Evidera Inc. and others are some of the top companies profiled in the report.
Check Global Personalized Therapy Biosimulation Market Research Report in Details: https://www.emergenresearch.com/industry-report/personalized-therapy-biosimulation-market
The report has classified the global Personalized Therapy Biosimulation industries into segments including product type and application. Every segment is evaluated based on growth rate and share. Besides, the analysts have studied the potential regions that may prove rewarding for the Personalized Therapy Biosimulation companies in the coming years. The regional analysis includes reliable predictions on value and volume, thereby helping market players to gain deep insights into the overall Personalized Therapy Biosimulation industry.
Emergen Research has segmented the global personalized therapy biosimulation market on the basis of product, therapeutic area, application end-use, and region:
Product Outlook (Revenue, USD Billion; 2018–2028)
Therapeutic Area Outlook (Revenue, USD Billion; 2018–2028)
Application Outlook (Revenue, USD Billion; 2018–2028)
End-use Outlook (Revenue, USD Billion; 2018–2028)
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
For Customised Template PDF Report: https://www.emergenresearch.com/request-for-customization/785
What is the goal of the report?
The market report presents the estimated size of the Personalized Therapy Biosimulation market at the end of the forecast period. The report also examines historical and current market sizes.
During the forecast period, the report analyzes the growth rate, market size, and market valuation.
The report presents current trends in the industry and the future potential of the North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa markets.
The report offers a comprehensive view of the market based on geographic scope, market segmentation, and key player financial performance.
Thank you for reading the research report. We also offer report customization as per client requirement. Kindly connect with us to know more about the customization feature and our team will offer you the best suited report.
Look Over transcripts provided by Emergen Research:
Medical Supplies Market https://www.emergenresearch.com/industry-report/medical-supplies-market
Gambling Software Market https://www.emergenresearch.com/industry-report/gambling-software-market
Traffic Jam Assist Systems Market https://www.emergenresearch.com/industry-report/traffic-jam-assist-systems-market
Blue Hydrogen Market https://www.emergenresearch.com/industry-report/blue-hydrogen-market
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: [email protected]
Visit for More Insights: https://www.emergenresearch.com/insights